Review decisions
Showing 110 results of 633 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1742223163746
Product Type: Drug
Control Number: 280534
DIN(s): 02537532, 02552566
Manufacturer: Arcutis Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-10-31
Decision / Authorization Date: 2024-10-17
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1739196670869
Product Type: Drug
Control Number: 281380
DIN(s): 02514222, 02514230, 02514249, 02514257
Manufacturer: Instituto Grifols, S.A.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-11-22
Decision / Authorization Date: 2024-11-18
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1761924898908
Product Type: Drug
Control Number: 292028
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2024-11-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1732546621694
Product Type: Drug
Control Number: 279169
DIN(s): 02417162, 02417170, 02469510
Manufacturer: AbbVie corp.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-09-18
Decision / Authorization Date: 2024-05-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1741877886786
Product Type: Drug
Control Number: 278103
DIN(s): 02480522
Manufacturer: ENDO Operations Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-08-04
Decision / Authorization Date: 2024-07-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1729085441755
Product Type: Drug
Control Number: 281318
DIN(s): 02468816
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-11-20
Decision / Authorization Date: 2024-10-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1729098917291
Product Type: Drug
Control Number: 281745
DIN(s): 02551012, 02551020, 02551039
Manufacturer: Novo Nordisk Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-12-01
Decision / Authorization Date: 2024-10-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1728568404321
Product Type: Drug
Control Number: 279827
DIN(s): 02527138
Manufacturer: Bristol-Myers Squibb Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-10-11
Decision / Authorization Date: 2024-09-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1727378042656
Product Type: Drug
Control Number: 279552
DIN(s): 02505541, 02505568
Manufacturer: Celgene Inc
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-09-29
Decision / Authorization Date: 2024-09-13
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1727284854344
Product Type: Drug
Control Number: 278399
DIN(s): 02456869
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-08-21
Decision / Authorization Date: 2024-08-29